Publications by authors named "Paul Marcoux"

Claim this Profile
P
Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes.
Catherine B Meador, Subba R Digumarthy, Beow Y Yeap, Yin P Hung, Mari Mino-Kenudson, J Paul Marcoux

Clin Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.
Allison E B Chang, Andrew J Piper-Vallillo, Raymond H Mak, Michael Lanuti, Alona Muzikansky, Paul Marcoux

Oncologist· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the overexpression of the tyrosine kinase receptor RET in the hematopoietic potential of induced pluripotent stem cells (iPSCs).
Paul Marcoux, Jusuf Imeri, Christophe Desterke, Theodoros Latsis, Diana Chaker

Cytotherapy· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis model.
Jusuf Imeri, Paul Marcoux, Matthias Huyghe, Christophe Desterke, Daianne Maciely Carvalho Fantacini

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling RET-Rearranged Non-Small Cell Lung Cancer (NSCLC): Generation of Lung Progenitor Cells (LPCs) from Patient-Derived Induced Pluripotent Stem Cells (iPSCs).
Paul Marcoux, Jin Wook Hwang, Christophe Desterke, Jusuf Imeri, Annelise Bennaceur-Griscelli

Cells· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillance.
Jusuf Imeri, Christophe Desterke, Paul Marcoux, Diana Chaker, Noufissa Oudrhiri

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs).
Jusuf Imeri, Christophe Desterke, Paul Marcoux, Gladys Telliam, Safa Sanekli

Cells· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of a genetic brain disease by CNS-wide microglia replacement.
Yohei Shibuya, Kevin K Kumar, Marius Marc-Daniel Mader, Yongjin Yoo, Luis Angel Ayala, Paul Marcoux

Sci Transl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical complications and clinical outcomes after dose-escalated trimodality therapy for non-small cell lung cancer in the era of intensity-modulated radiotherapy.
Kevin X Liu, Kailan Sierra-Davidson, Kevin Tyan, Lawrence T Orlina, J Paul Marcoux

Radiother Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID-19-associated organ failure.
Christophe Desterke, Frank Griscelli, Jusuf Imeri, Paul Marcoux, Thomas Lemonnier

Stem Cells Transl Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer.
Anne C Chiang, Lecia Van Dam Sequist, Jill Gilbert, Paul Conkling, Dana Thompson, J Paul Marcoux

Clin Lung Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis.
Yi Lee, Evan W Clark, Marina S D Milan, Christine Champagne, Kesi S Michael, J Paul Marcoux

JCO Precis Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer.
Anna F Farago, Beow Y Yeap, Marcello Stanzione, Yin P Hung, Rebecca S Heist, J Paul Marcoux

Cancer Discov· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
Mizuki Nishino, Emily S Chambers, Curtis R Chong, Nikhil H Ramaiya, Stacy W Gray, J Paul Marcoux

Cancer Immunol Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report of tracheobronchial squamous cell carcinoma treated with radiation therapy and concurrent chemotherapy.
Vishesh Agrawal, J Paul Marcoux, Michael S Rabin, Inna Vernovsky, Jon O Wee

Adv Radiat Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer.
David M Jackman, Leigh A Cioffredi, Lorraine Jacobs, Farhana Sharmeen, Linda K Morse, Paul J Marcoux

Oncotarget· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health behaviors, readiness to change, and interest in health promotion programs among smokers with lung cancer and their family members: a pilot study.
Mary E Cooley, Kathleen T Finn, Qian Wang, Kristin Roper, Sandra Morones, J Paul Marcoux

Cancer Nurs· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors.
Takaaki Sasaki, Jussi Koivunen, Atsuko Ogino, Masahiko Yanagita, Sarah Nikiforow, J Paul Marcoux

Cancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab monotherapy in patients with advanced non-small cell lung cancer after prior epidermal growth factor receptor tyrosine kinase inhibitor therapy.
Joel W Neal, Rebecca S Heist, Panos Fidias, Jennifer S Temel, Mark Huberman, J Paul Marcoux

J Thorac Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.
Jussi P Koivunen, Craig Mermel, Kreshnik Zejnullahu, Carly Murphy, Eugene Lifshits, J Paul Marcoux

Clin Cancer Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent thrombotic thrombocytopenic purpura (TTP) as a complication of acute relapsing pancreatitis.
Jayant A Talwalkar, Frederick W Ruymann, Paul Marcoux, Francis A Farraye

Dig Dis Sci· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis